BIOVISION ANNOUNCES ITS FIRST BIOVISION INVESTOR CONFERENCE March 25-26, 2013

BIOVISION ANNOUNCES ITS FIRST BIOVISION INVESTOR CONFERENCE March 25-26, 2013 – LYON, France

Venerdì 21 Dicembre 2012 14:31

The Selection Committee is composed with top-notch international investors from 9 different countries.
Roman Fleck, Principal, Index Ventures, a venture capital investment firm based in Geneva, Switzerland, will be chairing the Selection Committee.

Roman Fleck, comments: "This is a unique event in Europe that will showcase both the future industry leaders and the VC-backed leading start-up companies in one single event. The Selection Committee is happy to contribute and lead the gathering of the best European start-up companies in the Life Sciences.”

Didier Hoch, Executive Chairman, BIOVISION, comments:
“We are delighted to bring our proven experience and unique network of international decision-makers in Life Sciences to build this high-level investment conference in Europe. This initiative will allow us to demonstrate the contribution of BIOVISION in helping start-up companies finance their projects. The quality of the Selection Committee reflects the ambition of the BIOVISION Investor Conference. It also underscores our commitment to fostering innovation while supporting the growth of Life Sciences start-up companies.

BIOVISION INVESTOR CONFERENCE SELECTION COMMITTEE

Alain	Huriez	Advent Venture Partners
Marcel	Kloosterman	DSM Venturing
Lukas	Guenther	Wellington Partners Venture Capital
Ivica	Cerina	NGN Capital
Thom	Rasche	Earlybird Venture Capital
Jesus	Martin-Garcia	Eclosion
Diego	Braguglia	VI Partners AG
Angelo	De Rosa	Medtronic Europe
Sven	Rohmann	Burrill & Company
Manus	Rogan	Fountain Health Partners
Daniel	O'Mahony	Seroba Kernel
Celia	Hart	CEA Investissements
Isabelle	de Cremoux	Seventure
Franck	Lescure	Auriga Partners
Marie-Laure	Guarrigues	CDC entreprises
François	Valencony	Merieux Developpement
Françcois	Miceli	Sofimac
Joey	Mason	Delta Partners
Ilka	Wicke	Boehringer Ingelheim Venture Fund
Maciek	Drozdz	Entrepreneurs Fund Management LLP
Mark	Redshaw	Evonik Corporate Venturing
Claus	Andersson	Sunstone Capital
Maurizio	PetitBon	Kreos Capital
Hans	Kuepper	Global Life Sciences Ventures
Christina	Takke	Forbion Capital Partners
Jasper	Bos	Merck Serono Ventures
Davide	Turco	Altante Ventures (IntesaSanPaolo)
Muriel	Bekto	LifeScan J&J
Alexandra	Goll	TVM Capital
Aris	Constandinides	NBGI Ventures
Mark	Wilson	GlaxoSmithKline Pharmaceuticals
Antoine	Papiernik	Sofinnova Partners
Gérard	Hascoet	MDStart
Renee	Aguiar-Lucander	Omega Funds

About BIOVISION

BIOVISION is organized since 1999 in Lyon by the Fondation pour l’Université de Lyon, an independent non-profit organization. BIOVISION brings together top decision-makers from the academic, private, policy-making and civil society sectors to translate innovative ideas into actionable solutions for the benefit of citizens. The next edition of the BIOVISION World Life Sciences Forum will be held March 24-26, 2013 in Lyon, France. It expects more than 3,000 participants from 60 different countries, and 100 media representatives. BIOVISION is the place where key stakeholders debate over the impact of the latest scientific advances on society and share a prospective vision on how to overcome health, environment and nutrition challenges.
More information on BIOVISION, the World Life Sciences Forum, at www.BIOVISION.org.

BIOVISION ANNOUNCES ITS FIRST BIOVISION INVESTOR CONFERENCE March 25-26, 2013 – LYON, France

MEDIA CONTACT:
BIOVISION, the World Life Sciences Forum
Souad Gara
Communications Director
Phone: (33) 4 78 92 70 19
Mobile: (33) 6 20 51 68 37
Email: Questo indirizzo e-mail è protetto dallo spam bot. Abilita Javascript per vederlo.